BASF Commercializes Bacteria that Cleans Teeth

BASF says it has begun taking steps to commercialize a strain of Lactobacillus, a pro-biotic micro-organism, which it has engineered to protect against bacteria that cause cavities in teeth.   BASF says it has been collaborating with biotech firm OrganoBalance (Berlin) to commercialize the technology named pro-t-action. Financial terms between the two companies have not been disclosed. The strain of Lactobacillus developed by BASF and OrganoBalance binds to cavity-forming Streptococcus mutans bacteria found in the mouth, clumping them together so that they...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers